On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks

Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):303-5. doi: 10.1097/WAD.0b013e3181a80242.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Alzheimer Disease / blood*
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / epidemiology
  • Arizona / epidemiology
  • Cholesterol / blood*
  • Cognition Disorders / blood*
  • Cognition Disorders / drug therapy
  • Cognition Disorders / epidemiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol